Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,765.00p
   
  • Change Today:
    -22.00p
  • 52 Week High: 2,902.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 74,268
  • Market Cap: £1,165.46m
  • RiskGrade: 128

Latest ShareCast News

Genus holds gloomy guidance as tough conditions persist

By Benjamin Chiou

Date: Thursday 22 Feb 2024

(Sharecast News) - There were few surprises in Genus's interim results on Thursday after a detailed trading update from the animal genetics company just last week, as it reported a 31% drop in adjusted profits as expected.

London close: Stocks manage gains despite UK recession news

By Josh White

Date: Thursday 15 Feb 2024

(Sharecast News) - London markets had a mixed but ultimately positive day of trading on Thursday, despite news that the UK fell into a technical recession at the end of 2023.

Genus tumbles after warning on full-year profits

By Michele Maatouk

Date: Thursday 15 Feb 2024

(Sharecast News) - Genus shares tumbled on Thursday as the animal genetics company warned on full-year profits.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,765.00p
Change Today -22.00p
% Change -1.23 %
52 Week High 2,902.00
52 Week Low 1,637.00
Volume 74,268
Shares Issued 66.03m
Market Cap £1,165.46m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.03% below the market average96.03% below the market average96.03% below the market average96.03% below the market average96.03% below the market average
96.3% below the sector average96.3% below the sector average96.3% below the sector average96.3% below the sector average96.3% below the sector average
Price Trend
55.89% below the market average55.89% below the market average55.89% below the market average55.89% below the market average55.89% below the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average
Income
86.13% below the market average86.13% below the market average86.13% below the market average86.13% below the market average86.13% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
70.66% below the market average70.66% below the market average70.66% below the market average70.66% below the market average70.66% below the market average
72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 28-Mar-2024

Time Volume / Share Price
16:58 36 @ 1,785.75p
16:35 42,488 @ 1,765.00p
16:35 110 @ 1,765.00p
16:35 598 @ 1,765.00p
16:35 114 @ 1,765.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page